Quvium

Curated by Signal

Early warning solution for asthma patients

Overview

Quvium is developing CoughAware, a small wearable medical device to predict an asthmatic attack before it occurs. TheCoughAware device enables key early intervention and consequently contributes to the reduction in asthma attacks. It also secured a £500,000 loan from the government for developing the device.

Key facts

Founded: 2011
Headquarters: Ramsgate, United Kingdom
Stage: Sign up to view
Industry: High Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More High Technology companies

Archangel Imaging
Manufacturer of AI-based mobile surveillance cameras
High TechnologyHarwell, United Kingdom
Dogtooth Technologies
Manufacturer and supplier of robotic harvesters
High TechnologyRoyston, United Kingdom
Cognino
Provider of an explainable AI platform offering human-like understanding and learning
High TechnologyHarrow, United Kingdom

About Quvium

What does Quvium do?

Quvium is developing CoughAware, a small wearable medical device to predict an asthmatic attack before it occurs.

Where is Quvium headquartered?

Quvium is headquartered in Ramsgate, United Kingdom.

When was Quvium founded?

Quvium was founded in 2011.

Which sector is Quvium in?

Quvium operates in High Technology.

Who are Quvium's competitors?

Companies similar to Quvium include Archangel Imaging, Dogtooth Technologies, and Cognino.